Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

M Paul; GL Daikos; E Durante-Mangoni; D Yahav; Y Carmeli; YD Benattar; A Skiada; R Andini; N Eliakim-Raz; A Nutman; O Zusman; A Antoniadou; PC Pafundi; A Adler; Y Dickstein; I Pavleas; R Zampino; V Daitch; R Bitterman; H Zayyad; F Koppel; I Levi; T Babich; LE Friberg; Johan Mouton; U Theuretzbacher; L Leibovici

doi:10.1016/s1473-3099(18)30099-9

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

M Paul
, GL Daikos
, E Durante-Mangoni
, D Yahav
, Y Carmeli
, YD Benattar
, A Skiada
, R Andini
, N Eliakim-Raz
, A Nutman
, O Zusman
, A Antoniadou
, PC Pafundi
, A Adler
, Y Dickstein
, I Pavleas
, R Zampino
, V Daitch
, R Bitterman
, H Zayyad

F Koppel, I Levi, T Babich, LE Friberg, Johan Mouton, U Theuretzbacher, L Leibovici

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic

536 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	391-400
Number of pages	10
Journal	Lancet Infectious Diseases
Volume	18
Issue number	4
DOIs	https://doi.org/10.1016/s1473-3099(18)30099-9
Publication status	Published - 2018

Research programs

EMC MM-04-28-01

Access to Document

10.1016/s1473-3099(18)30099-9

http://hdl.handle.net/1765/104736

Cite this

Paul, M., Daikos, GL., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, YD., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., Zusman, O., Antoniadou, A., Pafundi, PC., Adler, A., Dickstein, Y., Pavleas, I., Zampino, R., Daitch, V., Bitterman, R., ... Leibovici, L. (2018). Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infectious Diseases, 18(4), 391-400. https://doi.org/10.1016/s1473-3099(18)30099-9

@article{bacf8c4faec04723b4d3faee4d0b12e2,

title = "Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial",

author = "M Paul and GL Daikos and E Durante-Mangoni and D Yahav and Y Carmeli and YD Benattar and A Skiada and R Andini and N Eliakim-Raz and A Nutman and O Zusman and A Antoniadou and PC Pafundi and A Adler and Y Dickstein and I Pavleas and R Zampino and V Daitch and R Bitterman and H Zayyad and F Koppel and I Levi and T Babich and LE Friberg and Johan Mouton and U Theuretzbacher and L Leibovici",

year = "2018",

doi = "10.1016/s1473-3099(18)30099-9",

language = "Undefined/Unknown",

volume = "18",

pages = "391--400",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "4",

}

Paul, M, Daikos, GL, Durante-Mangoni, E, Yahav, D, Carmeli, Y, Benattar, YD, Skiada, A, Andini, R, Eliakim-Raz, N, Nutman, A, Zusman, O, Antoniadou, A, Pafundi, PC, Adler, A, Dickstein, Y, Pavleas, I, Zampino, R, Daitch, V, Bitterman, R, Zayyad, H, Koppel, F, Levi, I, Babich, T, Friberg, LE, Mouton, J, Theuretzbacher, U & Leibovici, L 2018, 'Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial', Lancet Infectious Diseases, vol. 18, no. 4, pp. 391-400. https://doi.org/10.1016/s1473-3099(18)30099-9

TY - JOUR

T1 - Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

AU - Paul, M

AU - Daikos, GL

AU - Durante-Mangoni, E

AU - Yahav, D

AU - Carmeli, Y

AU - Benattar, YD

AU - Skiada, A

AU - Andini, R

AU - Eliakim-Raz, N

AU - Nutman, A

AU - Zusman, O

AU - Antoniadou, A

AU - Pafundi, PC

AU - Adler, A

AU - Dickstein, Y

AU - Pavleas, I

AU - Zampino, R

AU - Daitch, V

AU - Bitterman, R

AU - Zayyad, H

AU - Koppel, F

AU - Levi, I

AU - Babich, T

AU - Friberg, LE

AU - Mouton, Johan

AU - Theuretzbacher, U

AU - Leibovici, L

PY - 2018

Y1 - 2018

U2 - 10.1016/s1473-3099(18)30099-9

DO - 10.1016/s1473-3099(18)30099-9

M3 - Article

SN - 1473-3099

VL - 18

SP - 391

EP - 400

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 4

ER -